or Try an Advanced Search...

    Technical Analysis for CABA - Cabaletta Bio, Inc.

    Grade Last Price % Change Price Change
    F 2.01 -11.06% -0.25
    CABA closed down 11.02 percent on Wednesday, November 20, 2024, on 2.27 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CABA trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish -11.06%
    Lower Bollinger Band Walk Weakness -11.06%
    New 52 Week Low Weakness -11.06%
    Wide Bands Range Expansion -11.06%
    Below Lower BB Weakness -11.06%
    Down 3 Days in a Row Weakness -11.06%
    Down 4 Days in a Row Weakness -11.06%
    Down 5 Days in a Row Weakness -11.06%
    Lower Bollinger Band Touch Weakness -11.06%
    Oversold Stochastic Weakness -11.06%
    Older End-of-Day Signals for CABA ...

       Recent Intraday Alerts

    Alert Time
    3x Volume Pace about 3 hours ago
    Down 10% about 3 hours ago
    2x Volume Pace about 3 hours ago
    Down 5% about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CABA Chart by TradingView
    Basic chart:

    Profile

    Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Immunology Autoimmune Disease Antibodies Autoimmunity T Cell Sjögren Syndrome

    Is CABA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
    Nov 14 Cabaletta Bio GAAP EPS of -$0.62 misses by $0.03
    Nov 14 Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 6 Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
    Oct 30 We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate
    Oct 22 Cabaletta: Biotech With Large Potential, Interesting Bottom Pattern, Plenty Of Cash
    Oct 17 State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings
    Oct 10 Kyverna, Cabaletta started at buys by UBS on CAR T therapy potential
    Sep 25 Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
    Aug 28 Cabaletta Bio to Participate in Upcoming Investor Conferences in September
    See more CABA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.35
    52 Week Low 2.18
    Average Volume 1,096,124
    200-Day Moving Average 10.30
    50-Day Moving Average 4.12
    20-Day Moving Average 3.81
    10-Day Moving Average 3.62
    Average True Range 0.40
    RSI (14) 25.37
    ADX 20.31
    +DI 13.42
    -DI 42.46
    Chandelier Exit (Long, 3 ATRs) 3.54
    Chandelier Exit (Short, 3 ATRs) 3.39
    Upper Bollinger Bands 5.14
    Lower Bollinger Band 2.48
    Percent B (%b) -0.08
    BandWidth 69.85
    MACD Line -0.41
    MACD Signal Line -0.20
    MACD Histogram -0.2017
    Fundamentals Value
    Market Cap 96.84 Million
    Num Shares 42.8 Million
    EPS -1.70
    Price-to-Earnings (P/E) Ratio -1.33
    Price-to-Sales 0.00
    Price-to-Book 6.65
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.92
    Resistance 3 (R3) 2.97 2.79 2.81
    Resistance 2 (R2) 2.79 2.63 2.77 2.77
    Resistance 1 (R1) 2.53 2.52 2.44 2.48 2.74
    Pivot Point 2.35 2.35 2.31 2.33 2.35
    Support 1 (S1) 2.09 2.19 2.00 2.04 1.78
    Support 2 (S2) 1.91 2.08 1.89 1.75
    Support 3 (S3) 1.65 1.91 1.71
    Support 4 (S4) 1.60